Vesicular Monoamine Transport Proteins
"Vesicular Monoamine Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.
| Descriptor ID |
D050493
|
| MeSH Number(s) |
D12.776.157.530.450.162.887.500.500 D12.776.157.530.562.750.500.500 D12.776.543.585.450.162.887.500.500 D12.776.543.585.562.750.500.500
|
| Concept/Terms |
Vesicular Monoamine Transport Proteins- Vesicular Monoamine Transport Proteins
- Vesicular Monoamine Transporter Proteins
- Monoamine Vesicular Transporter
- Vesicular Transporter, Monoamine
- Vesicular Monoamine Transporter
- Monoamine Transporter, Vesicular
- Monoamine Transporters, Vesicular
- Vesicular Monoamine Transporters
- Monoamine Vesicular Transport Proteins
Vesicular Monoamine Transporter 1- Vesicular Monoamine Transporter 1
- VMAT-1 Vesicular Monoamine Transporter
- VMAT 1 Vesicular Monoamine Transporter
- Chromaffin Granule Amine Transporter
|
Below are MeSH descriptors whose meaning is more general than "Vesicular Monoamine Transport Proteins".
Below are MeSH descriptors whose meaning is more specific than "Vesicular Monoamine Transport Proteins".
This graph shows the total number of publications written about "Vesicular Monoamine Transport Proteins" by people in this website by year, and whether "Vesicular Monoamine Transport Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vesicular Monoamine Transport Proteins" by people in Profiles.
-
Valbenazine in the treatment of tardive dyskinesia. Neurodegener Dis Manag. 2019 04; 9(2):73-81.
-
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study. J Clin Psychiatry. 2017 Nov/Dec; 78(9):1344-1350.
-
Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: positive and negative effects. Brain Res. 2014 Mar 06; 1550:47-60.
-
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord. 2008 Dec 15; 23(16):2303-6.